Phase I/II Study of Concurrent Cisplatin, Pemetrexed, and Radiotherapy for Limited Stage Small Cell Lung Cancer.
Phase of Trial: Phase I/II
Latest Information Update: 02 Jun 2011
At a glance
- Drugs Cisplatin; Pemetrexed
- Indications Small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- Sponsors Eli Lilly
- 01 Sep 2009 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 07 Dec 2008 Status changed from discontinued to completed, according to ClinicalTrials.gov.
- 28 Jan 2008 Status changed from recruiting to discontinued. The trial was terminated due to results of interim data analysis suggesting lack of efficacy. Updated from ClinicalTrials.gov.